When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time)
Health & MedicineOne-Off3moisManifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleDecember 2026 36%En tête parmi 7 options
Prévisionnistes
6
Type de question
multiple choice
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Variation 7j
0.0 pts
Données du marché
Mis à jour il y a 1 heure
En retard7 juil. 26, 22:11 UTC2 janv. 27, 04:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Intoxicating hemp-derived THC products federally banned in U.S. by end of 2026?
Manifold MarketsWill hemp-derived CBN sleep products still be federally legal as “hemp” on Nov 12, 2026?
Manifold MarketsWill Lego release a set for 'Fountain' by Duchamp by the end of 2030?
Manifold MarketsEbola pandemic in 2026?
PolymarketHantavirus pandemic in 2026?
PolymarketFDA approves skin cancer vaccine by which date?
PolymarketRègles
The FDA is under pressure to approve nicotine products under the PMTA (Premarket Tobacco Product Application) pathway.
- They have permitted products without FDA marketing authorization to remain available while the applications are under review.
- Resolution Criteria: Resolves to the FDA official website which lists authorizations
- Resolution Sources: .gov websites, official press releases
Marchés ouverts
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Volume total
- 15,6 M €
- Volume 24h
- 35,6 k €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.9pt3%
- Volume total
- 1,6 M €
- Volume 24h
- 5,2 k €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Volume total
- 83,5 k €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt96%
- Above 6000-4.0pt58%
+2 résultats de plus
- Volume total
- 864,2 k €
- Volume 24h
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- 915,8 k €
- Volume 24h
- 1,5 k €
KALSHIWhen will the FDA approve Intellia Therapeutics' lonvo-z?
- Before July 2027+67.0pt97%
- Before 202872%
- Before October 202752%
- Volume total
- 4,2 k €
- Volume 24h
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- When will the FDA reclassify BPC-157 to Category 1?
- Ebola pandemic in 2026?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- Will the FDA approve CagriSema?
Questions fréquentes
- Quelles sont les probabilités actuelles pour When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time) ?
- Manifold Markets cote December 2026 à 36% au 9 septembre 2026.
- Quand When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time) sera-t-il résolu ?
- When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time) doit être résolu le 2 janvier 2027.
- Comment When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time) est-il réglé ?
- Manifold Markets règle ce marché comme suit : The FDA is under pressure to approve nicotine products under the PMTA (Premarket Tobacco Product Application) pathway.